Clinical Practice Guidelines


Clinical Practice Guidelines are defined as systematically developed recommendations accompanied by a systematically derived background summary of the quality of evidence and the potential benefits and harms to assist practitioner and patient decisions about appropriate health care for specific clinical circumstances.” 1

 

The Canadian Dermatology Association (CDA) is committed to making its guideline development process open and transparent so all interested healthcare professionals, patients and patient carers can easily identify opportunities to submit guideline topic suggestions, participate in the development of a guideline, and/or follow a guideline’s progress.

Under the CDA guideline framework, three bodies are responsible for bringing a guideline topic from a clinical question to publishing recommendations in the CDA’s official journal, the Journal of Cutaneous Medicine and Surgery. The first is the Clinical Practice Guidelines Working Group. They provide important oversight by establishing policy and guidance documents, and making guideline topic and chair recommendations to the Board of Directors. The second is the Board of Directors. As the leadership body for the CDA, they are entrusted with the responsibility to accept or reject all policy, guideline topic, and chair appointment recommendations. Last is the Guideline Development Group. Once a chair is (or co-chairs are) appointed to a Guideline Development Group, they are responsible for identifying and confirming the membership appointments needed to complete their assigned clinical practice guideline.

Guidelines Under Development

The following chart is a current list active Guideline Development Groups in alphabetical order and identifies key engagement opportunities (refer to bolded text) along with other status information. Activity status tags used in this chart are: (1) chair application open, (2) chair application closed, (3) membership applications open, (4) membership applications closed, (5) guideline in development, (6) guideline comments open, (7) guideline comments closed, or (8) guideline submitted for publication.

Guideline Development Group Current Activity Status Posting Date
Actinic Keratoses Member applications open September 2019
Screening for Melanoma Member applications open September 2019
Warts Member applications open September 2019
The CDA welcomes submissions for topic nominations throughout the year and encourages all members and interested stakeholders to apply for Guideline Development Group positions of interest.  

To learn more about the processes for submitting a topic nomination or applying for a chair or member position on a Guideline Development Group, please refer to the sections below.

Struggling with a clinical decision due to conflicting studies or uncertainty about benefits or harm? All CDA members, healthcare providers involved in the care of dermatologic patients, and interested stakeholders are invited to nominate clinical practice guideline topics for consideration by the CDA.

Nominations are to be made online and may be submitted throughout the year. All nominations will be scored and prioritized based on the following six criteria:

Current Situation:

  1. Prevalence of the clinical problem.
  2. Burden of illness imposed by the problem: individual mortality, morbidity, or functional impairment.
  3. Cost of managing the problem
  4. Variability in practice: significant differences in utilization rates for prevention, diagnosis, or treatment options.

Potential Impact:

  1. Potential of a guideline or assessment to improve health outcomes: expected effect on health outcomes.
  2. Potential of guideline or assessment to reduce costs: expected effect on costs to patients and families, relevant organizations and societies, and/or society in general.

Supporting documents may also be uploaded when submitting nominations.

The CDA may contact the topic nominator to ask additional clarifying questions about the research question(s) posed in the nomination and its scope if the nominator provides permission to contact him or her.

All submitted nomination topics will be posted on the CDA website unedited by date of receipt along with a status notification, i.e. “under review”, “accepted”, or “rejected”.  For the latter, a rationale for acceptance or rejection will also be provided.

Nomination Form
Guideline Topic Nominations Received Activity Status* Decision Rationale
There are currently no topic nominations.
* Activity status tags used for nominated topics are: under review, accepted, or rejected.

Interested in Chairing a Guideline Development Group? Chair candidates must be a CDA member and be completely free of any COIs (this includes both direct and indirect interests) with respect to the subject of the guideline topic. Chair candidates are not required to be a content expert for the guideline topic but should be familiar with the scientific literature and management of the clinical condition.

Chair candidates must possess leadership strengths and be knowledgeable of research methodologies. Appointed chairs are expected to define the purpose and scope of their guideline topic, identify and approve the membership needed to complete the guideline work, outline expectations and timelines, ensure inclusiveness of all membership’s interests, and identify any budgetary needs. All chairs must complete a Conflict of Interest Disclosure Form to be considered.

Appointed chairs are to serve on a volunteer basis and to sign a non-disclosure agreement with respect to their guideline work. Chair names, as well as the names of guideline development group members, will not be announced until the prepublication draft of the guideline is posted for comment. Similarly, the names of all those providing financial support through the CDA’s Corporate Supporter Program will also be withheld until the guideline is submitted for publication. These actions are taken to allay any suggestion of possible influence.

Chairs will be listed as first and corresponding authors on all published guidelines.

To learn more, the following publications will be of interest:

Application Form

Interested in being a Member of a Guideline Development Group? Member candidates can be certified dermatologists, healthcare professionals involved in the care of patients affected by the guideline, as well as patients and patient carers with direct experience of the condition.

Member candidates should be familiar with guideline development methodology, be able to attend meetings and meet assignment deadlines. Dermatologists and other healthcare professional members will also be expected to provide content expertise for the guideline topic. Similarly, patient and patient carers are expected to provide patient-centred perspectives to ensure content and language is relatable and sensitively worded. All members must complete a Conflict of Interest Disclosure Form to be considered.

Appointed members are to serve on a volunteer basis and to sign a non-disclosure agreement with respect to their guideline work. Member names, as well as the name of their guideline development group chair, will not be announced until the prepublication draft of the guideline is posted for comment. Further, the names of all those providing financial support through the CDA’s Corporate Supporter Program will also be withheld until the guideline is submitted for publication. These actions are taken to allay any suggestion of possible influence.

Members will be named as authors on published guidelines in order of their contribution to the guideline.

To learn more, the following publications will be of interest:

Application Form

Financial Support

Funding for the development of CDA’s clinical practice guidelines is provided through the pooled funds under the CDA’s Corporate Supporter Program. This is done to ensure equitable funding is available for all topics without prejudice. If you would like more information on how you may financially support the ongoing development of the CDA’s clinical practice guidelines, contact Ms. Jonelle Istead, Director, Development, at jistead@dermatology.ca.

1Singh H. et al. Canadian Association of Gastroenterology policy on the application for, and implementation of, clinical practice guidelines. Can J Gastroenterol Hepatol. 2014 Oct;28(9):473-80.